117 related articles for article (PubMed ID: 38215552)
21. The epithelial sodium-hydrogen antiporter Na+/H+ exchanger 3 accumulates and is functional in recycling endosomes.
D'Souza S; Garcia-Cabado A; Yu F; Teter K; Lukacs G; Skorecki K; Moore HP; Orlowski J; Grinstein S
J Biol Chem; 1998 Jan; 273(4):2035-43. PubMed ID: 9442041
[TBL] [Abstract][Full Text] [Related]
22. The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.
Prasad H; Rao R
J Biol Chem; 2015 Feb; 290(9):5311-27. PubMed ID: 25561733
[TBL] [Abstract][Full Text] [Related]
23. Cell surface levels of organellar Na+/H+ exchanger isoform 6 are regulated by interaction with RACK1.
Ohgaki R; Fukura N; Matsushita M; Mitsui K; Kanazawa H
J Biol Chem; 2008 Feb; 283(7):4417-29. PubMed ID: 18057008
[TBL] [Abstract][Full Text] [Related]
24. Human lactoferrin triggers a mitochondrial- and caspase-dependent regulated cell death in Saccharomyces cerevisiae.
Acosta-Zaldívar M; Andrés MT; Rego A; Pereira CS; Fierro JF; Côrte-Real M
Apoptosis; 2016 Feb; 21(2):163-73. PubMed ID: 26577769
[TBL] [Abstract][Full Text] [Related]
25. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.
Ando K; Hasegawa K; Shindo K; Furusawa T; Fujino T; Kikugawa K; Nakano H; Takeuchi O; Akira S; Akiyama T; Gohda J; Inoue J; Hayakawa M
FEBS J; 2010 May; 277(9):2051-66. PubMed ID: 20345905
[TBL] [Abstract][Full Text] [Related]
26. Growth suppression effects of recombinant adenovirus expressing human lactoferrin on cervical cancer in vitro and in vivo.
Li WY; Li QW; Han ZS; Jiang ZL; Yang H; Li J; Zhang XB
Cancer Biother Radiopharm; 2011 Aug; 26(4):477-83. PubMed ID: 21834714
[TBL] [Abstract][Full Text] [Related]
27. Harnessing the chondroitin sulfate-binding characteristics of human lactoferrin to neutralize neurite outgrowth inhibition.
Nakamura M; Matsuzaki T; Iimori A; Sato A
Biochem Biophys Res Commun; 2021 Jan; 534():1076-1082. PubMed ID: 33129446
[TBL] [Abstract][Full Text] [Related]
28. Candidacidal activities of human lactoferrin peptides derived from the N terminus.
Lupetti A; Paulusma-Annema A; Welling MM; Senesi S; van Dissel JT; Nibbering PH
Antimicrob Agents Chemother; 2000 Dec; 44(12):3257-63. PubMed ID: 11083624
[TBL] [Abstract][Full Text] [Related]
29. A recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation.
Khayat W; Hackett A; Shaw M; Ilie A; Dudding-Byth T; Kalscheuer VM; Christie L; Corbett MA; Juusola J; Friend KL; Kirmse BM; Gecz J; Field M; Orlowski J
Hum Mol Genet; 2019 Feb; 28(4):598-614. PubMed ID: 30335141
[TBL] [Abstract][Full Text] [Related]
30. Testing Antimicrobial Properties of Human Lactoferrin-Derived Fragments.
Ostrówka M; Duda-Madej A; Pietluch F; Mackiewicz P; Gagat P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445717
[TBL] [Abstract][Full Text] [Related]
31. Surface display of human lactoferrin using a glycosylphosphatidylinositol-anchored protein of Saccharomyces cerevisiae in Pichia pastoris.
Jo JH; Im EM; Kim SH; Lee HH
Biotechnol Lett; 2011 Jun; 33(6):1113-20. PubMed ID: 21267758
[TBL] [Abstract][Full Text] [Related]
32. Albumin and glucose effects on cell growth parameters, albumin uptake and Na(+)/H(+)-exchanger Isoform 3 in OK cells.
Drumm K; Lee E; Stanners S; Gassner B; Gekle M; Poronnik P; Pollock C
Cell Physiol Biochem; 2003; 13(4):199-206. PubMed ID: 12876377
[TBL] [Abstract][Full Text] [Related]
33. Intracellular pH activates membrane-bound Na(+)/H(+) exchanger and vacuolar H(+)-ATPase in human embryonic kidney (HEK) cells.
Lang K; Wagner C; Haddad G; Burnekova O; Geibel J
Cell Physiol Biochem; 2003; 13(5):257-62. PubMed ID: 14586169
[TBL] [Abstract][Full Text] [Related]
34. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
[TBL] [Abstract][Full Text] [Related]
35. Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger.
Saini HK; Dhalla NS
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2790-800. PubMed ID: 16861694
[TBL] [Abstract][Full Text] [Related]
36. Interaction of human lactoferrin with the rat liver.
Debanne MT; Regoeczi E; Sweeney GD; Krestynski F
Am J Physiol; 1985 Apr; 248(4 Pt 1):G463-9. PubMed ID: 2984944
[TBL] [Abstract][Full Text] [Related]
37. Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia and Prevotella melaninogenica.
Kalfas S; Andersson M; Edwardsson S; Forsgren A; Naidu AS
Oral Microbiol Immunol; 1991 Dec; 6(6):350-5. PubMed ID: 1726544
[TBL] [Abstract][Full Text] [Related]
38. The sodium/proton exchanger NHE8 regulates late endosomal morphology and function.
Lawrence SP; Bright NA; Luzio JP; Bowers K
Mol Biol Cell; 2010 Oct; 21(20):3540-51. PubMed ID: 20719963
[TBL] [Abstract][Full Text] [Related]
39. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
40. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
